TiHo-0906: a New Feline Mammary Cancer Cell Line with Molecular, Morphological, and Immunocytological Characteristics of Epithelial to Mesenchymal Transition

Overview

Journal Sci Rep

Specialty Science

Date 2018 Sep 7

PMID 30185896

Citations 5

Authors

Jose Luis Granados-Soler

Johannes Junginger

Marion Hewicker-Trautwein

Kirsten Bornemann-Kolatzki

Julia Beck

Bertram Brenig

Daniela Betz

Jan Torben Schille

Hugo Murua Escobar

Ingo Nolte

Affiliations

Soon will be listed here.

Abstract

Feline mammary carcinomas (FMCs) with anaplastic and malignant spindle cells histologically resemble the human metaplastic breast carcinoma (hMBC), spindle-cell subtype. hMBCs display epithelial-to-mesenchymal transition (EMT) characteristics. Herein we report the establishment and characterization of a cell line (TiHoCMglAdcar0906; TiHo-0906) exhibiting EMT-like properties derived from an FMC with anaplastic and malignant spindle cells. Copy-number variations (CNVs) by next-generation sequencing and immunohistochemical characteristics of the cell line and the tumour were compared. The absolute qPCR expression of EMT-related markers HMGA2 and CD44 was determined. The growth, migration, and sensitivity to doxorubicin were assessed. TiHo-0906 CNVs affect several genomic regions harbouring known EMT-, breast cancer-, and hMBCs-associated genes as AKT1, GATA3, CCND2, CDK4, ZEB1, KRAS, HMGA2, ESRP1, MTDH, YWHAZ, and MYC. Most of them were located in amplified regions of feline chromosomes (FCAs) B4 and F2. TiHo-0906 cells displayed an epithelial/mesenchymal phenotype, and high HMGA2 and CD44 expression. Growth and migration remained comparable during subculturing. Low-passaged cells were two-fold more resistant to doxorubicin than high-passaged cells (IC50: 99.97 nM, and 41.22 nM, respectively). The TiHo-0906 cell line was derived from a poorly differentiated cellular subpopulation of the tumour consistently displaying EMT traits. The cell line presents excellent opportunities for studying EMT on FMCs.

Citing Articles

Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways.

Granados-Soler J, Taher L, Beck J, Bornemann-Kolatzki K, Brenig B, Nerschbach V Sci Rep. 2022; 12(1):17025.

PMID: 36220861 PMC: 9553959. DOI: 10.1038/s41598-022-20874-5.

Effects of hsa-miR-28-5p on Adriamycin Sensitivity in Diffuse Large B-Cell Lymphoma.

Yan S, Shang Q, Zhu H, Chen K, Li X, Gao H Evid Based Complement Alternat Med. 2022; 2022:4290994.

PMID: 35873635 PMC: 9300279. DOI: 10.1155/2022/4290994.

Establishment and Characterization of Feline Mammary Tumor Patient-Derived Xenograft Model.

Chuang H, Chang Y, Huang Y, Liao J, Kao P, Chen Y Animals (Basel). 2021; 11(8).

PMID: 34438836 PMC: 8388766. DOI: 10.3390/ani11082380.

Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.

Packeiser E, Hewicker-Trautwein M, Thiemeyer H, Mohr A, Junginger J, Schille J PLoS One. 2020; 15(3):e0230272.

PMID: 32168360 PMC: 7069630. DOI: 10.1371/journal.pone.0230272.

Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival.

Granados-Soler J, Bornemann-Kolatzki K, Beck J, Brenig B, Schutz E, Betz D Sci Rep. 2020; 10(1):1003.

PMID: 31969654 PMC: 6976565. DOI: 10.1038/s41598-020-57942-7.

References

Castagnaro M, Casalone C, Bozzetta E, De Maria R, Biolatti B, Caramelli M . Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas. J Comp Pathol. 1998; 119(3):263-75. DOI: 10.1016/s0021-9975(98)80049-2. View

Wiese D, Thaiwong T, Yuzbasiyan-Gurkan V, Kiupel M . Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype. BMC Cancer. 2013; 13:403. PMC: 3849986. DOI: 10.1186/1471-2407-13-403. View

Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M . The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene. 2007; 26(49):6979-88. PMC: 2899859. DOI: 10.1038/sj.onc.1210508. View

Soares M, Correia J, Rodrigues P, Simoes M, de Matos A, Ferreira F . Feline HER2 protein expression levels and gene status in feline mammary carcinoma: optimization of immunohistochemistry (IHC) and in situ hybridization (ISH) techniques. Microsc Microanal. 2013; 19(4):876-82. DOI: 10.1017/S1431927613001529. View

Iida N, Bourguignon L . New CD44 splice variants associated with human breast cancers. J Cell Physiol. 1995; 162(1):127-33. DOI: 10.1002/jcp.1041620115. View

Matsuda K, Kobayashi S, Yamashita M, Hirayama K, Kadosawa T, Taniyama H . Tubulopapillary carcinoma with spindle cell metaplasia of the mammary gland in a cat. J Vet Med Sci. 2008; 70(5):479-81. DOI: 10.1292/jvms.70.479. View

Zhao M, Liu Y, Qu H . Expression of epithelial-mesenchymal transition-related genes increases with copy number in multiple cancer types. Oncotarget. 2016; 7(17):24688-99. PMC: 5029734. DOI: 10.18632/oncotarget.8371. View

Battula V, Evans K, Hollier B, Shi Y, Marini F, Ayyanan A . Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells. 2010; 28(8):1435-45. PMC: 3523728. DOI: 10.1002/stem.467. View

Arumugam T, Ramachandran V, Fournier K, Wang H, Marquis L, Abbruzzese J . Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 2009; 69(14):5820-8. PMC: 4378690. DOI: 10.1158/0008-5472.CAN-08-2819. View

10.

Singh A, Settleman J . EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010; 29(34):4741-51. PMC: 3176718. DOI: 10.1038/onc.2010.215. View

11.

Tsai J, Yang J . Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013; 27(20):2192-206. PMC: 3814640. DOI: 10.1101/gad.225334.113. View

12.

Flores A, Rema A, Carvalho F, Faustino A, Dias Pereira P . Reduced expression of claudin-2 is associated with high histological grade and metastasis of feline mammary carcinomas. J Comp Pathol. 2013; 150(2-3):169-74. DOI: 10.1016/j.jcpa.2013.09.004. View

13.

Brunetti B, Asproni P, Beha G, Muscatello L, Millanta F, Poli A . Molecular phenotype in mammary tumours of queens: correlation between primary tumour and lymph node metastasis. J Comp Pathol. 2012; 148(2-3):206-13. DOI: 10.1016/j.jcpa.2012.05.012. View

14.

Cursons J, Leuchowius K, Waltham M, Tomaskovic-Crook E, Foroutan M, Bracken C . Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines. Cell Commun Signal. 2015; 13:26. PMC: 4432969. DOI: 10.1186/s12964-015-0106-x. View

15.

Korsching E, Packeisen J, Liedtke C, Hungermann D, Wulfing P, van Diest P . The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?. J Pathol. 2005; 206(4):451-7. DOI: 10.1002/path.1797. View

16.

Zappulli V, Rasotto R, Caliari D, Mainenti M, Pena L, Goldschmidt M . Prognostic evaluation of feline mammary carcinomas: a review of the literature. Vet Pathol. 2014; 52(1):46-60. DOI: 10.1177/0300985814528221. View

17.

Luo Y, Li W, Liao H . HMGA2 induces epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells. Oncol Lett. 2013; 5(4):1353-1356. PMC: 3629159. DOI: 10.3892/ol.2013.1193. View

18.

McKinnon E, Xiao P . Metaplastic carcinoma of the breast. Arch Pathol Lab Med. 2015; 139(6):819-22. DOI: 10.5858/arpa.2013-0358-RS. View

19.

May C, Sphyris N, Evans K, Werden S, Guo W, Mani S . Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res. 2011; 13(1):202. PMC: 3109556. DOI: 10.1186/bcr2789. View

20.

Cleynen I, Van de Ven W . The HMGA proteins: a myriad of functions (Review). Int J Oncol. 2008; 32(2):289-305. View